Results 181 to 190 of about 790,447 (335)

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

CD8+ T-cell Antitumor Immunity via Human iNKT-DC Conjugates. [PDF]

Cancer Immunol Res
Baiu DC, Smith KA, Ferguson SA, Schwartz NR, Tripathy S, Brand J, Dinh HQ, Ohashi M, Johannsen EC, Gumperz JE.   +9 more
europepmc   +1 more source

Molecular cloning and characterization of mouse mammary tumor proviruses from a T-cell lymphoma [PDF]

, 1986
Jaquelin P. Dudley, Ann Arfsten, Chih-Li Lilian Hsu, Christine A. Kozak, R Risser   +4 more
openalex   +1 more source

SI Figures from Myeloma Cell Dynamics in Response to Treatment Supports a Model of Hierarchical Differentiation and Clonal Evolution

, 2023
Min Tang, Rui Zhao, Helgi van de Velde, Jennifer G. Tross, Constantine S. Mitsiades, Suzanne Viselli, Rachel Neuwirth, Dixie‐Lee Esseltine, Kenneth C. Anderson, Irene M. Ghobrial, Jesús F. San Miguel, Paul G. Richardson, Michael H. Tomasson, Franziska Michor   +13 more
openalex   +2 more sources

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Phenotypic Characterization and Prognostic Impact of CD103+ Tissue-Resident Memory T Cells in Diffuse Large B-cell Lymphoma. [PDF]

Cancer Immunol Res
Savage G, Milne K, Collinge B, Yin Y, Loos P, Warren ME, Laumont CM, Keith D, Nelson BH, Venturutti L, Weng AP, Scott DW, Steidl C, Evgin L.   +13 more
europepmc   +1 more source

Rat complement factor I: molecular cloning, sequencing and expression in tissues and isolated cells [PDF]

, 1999
Gerald Schlaf, Ellen Rothermel, Martin Oppermann, Henrike L. Schieferdecker, Kurt Jungermann, Otto Götze   +5 more
openalex   +1 more source

Cloned stem cells [PDF]

Genome Biology, 2001
openaire   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

Molecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen   +5 more
wiley   +1 more source

DF6215, an α-optimized IL-2-Fc fusion, expands immune effectors and drives robust preclinical anti-tumor activity. [PDF]

Cell Rep Med
Stockmann AP, Vincent S, Herschelman L, Huang CS, Ma J, Fallon D, Kirby P, Gutierrez E, Talbot D, Hicks SW, Wagtmann N, Cheung AF.   +11 more
europepmc   +1 more source